Key facts
- Notable investors include Even One Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Echo Immune
- ·The full record, as it builds
Funding rounds
No funding rounds for Echo Immune are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Echo Immune
Developer of personalized mRNA cancer vaccines intended to prevent cancer recurrence by targeting residual tumor cells with precision therapies. The company is currently operating in Stealth Mode.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Website
- echoimmune.com/
- Ownership
- Privately Held (backing)
Echo Immune doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Echo Immune shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Echo Immune in its N-PORT filings yet. We sweep new filings monthly.